Dapagliflozin Inhibits Ventricular Remodeling in Heart Failure Rats by Activating Autophagy through AMPK/mTOR Pathway

OBJECTIVE: Heart failure (HF) is the end stage of heart disease caused by various factors which mainly involves ventricular remodeling (VR). In HF patients with reduced ejection fraction, dapagliflozin (DAPA) reduced the risk of worsening HF or cardiovascular death. Thus, we attempted to clarify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Honghong, Ma, Yanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525743/
https://www.ncbi.nlm.nih.gov/pubmed/36193200
http://dx.doi.org/10.1155/2022/6260202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525743/
https://www.ncbi.nlm.nih.gov/pubmed/36193200
http://dx.doi.org/10.1155/2022/6260202

Ejemplares similares